Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Is Ocular Therapeutix (OCUL) Pricing Reflect Its Volatile Returns And Rich Sales Multiple?

If you are trying to work out whether Ocular Therapeutix at around US$8.76 is a bargain or just fairly priced, starting with a clear view of its valuation can help frame your next move. The stock has seen mixed returns, with a 14.7% decline over the last 7 days and a 4.4% decline over the last 30 days, while the 1 year return sits at 13.5% and the 3 year return at 76.6%, compared with a 57.6% decline over 5 years. Recent market attention on Ocular Therapeutix has focused on its progress as...
ENXTPA:ORA
ENXTPA:ORATelecom

Assessing Orange’s (ENXTPA:ORA) Valuation After SafeCycloMove Smart Mobility Trial Success

Orange (ENXTPA:ORA) is in focus after taking part in the SafeCycloMove Collision Prevention live trial in Bordeaux, where its app integration helped support vehicle-to-everything alerts between buses and cyclists. See our latest analysis for Orange. For shareholders, Orange’s recent smart mobility work sits alongside a solid run in the market, with a 90 day share price return of 28.07% and a 1 year total shareholder return of 56.78%. This points to momentum that has also compounded into a 5...
ASX:TBR
ASX:TBRMetals and Mining

Tribune Resources (ASX:TBR) Net Margin Jump Reinforces Bullish Profitability Narratives

Tribune Resources H1 2026 earnings snapshot Tribune Resources (ASX:TBR) has put fresh numbers on the table for H1 2026, with revenue of A$97.3 million, basic EPS of A$0.58 and trailing twelve month EPS of A$0.84 framing the latest read on profitability. The company has seen revenue move from A$91.6 million in H1 2025 to A$68.8 million in H2 2025 and then to A$97.3 million in H1 2026. Basic EPS shifted from A$0.37 to A$0.27 across 2025 halves before landing at A$0.58 this half, giving...
TSX:EDR
TSX:EDRMetals and Mining

Is It Too Late To Consider Endeavour Silver (TSX:EDR) After Its Sharp Pullback?

If you are wondering whether Endeavour Silver's share price still reflects good value after its recent run, you are not alone. This article will focus squarely on what investors are paying versus what they may be getting. The stock last closed at US$13.69, with returns of 10.3% year to date and 102.5% over the past year. However, the share price has pulled back, with a 10.1% decline over 7 days and an 18.5% decline over 30 days. Recent news around Endeavour Silver has centered on ongoing...
NYSE:BF.B
NYSE:BF.BBeverage

Assessing Brown‑Forman (BF.B) Valuation After Bernstein Downgrade And Softer 2026 Guidance

Brown-Forman (BF.B) is back in focus after Bernstein cut its rating, citing ongoing margin pressure from higher barrelled whisky costs and softer demand, even though recent quarterly results came in ahead of expectations. See our latest analysis for Brown-Forman. At a share price of $23.49, Brown-Forman has seen momentum fade, with a 30 day share price return of 22.42% and a 90 day share price return of 23.63%. The 5 year total shareholder return of 62.11% highlights how prolonged the...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

Is It Time To Reassess BioMarin Pharmaceutical (BMRN) After Prolonged Share Price Weakness

How BioMarin Pharmaceutical’s Recent Moves Set Up a Closer Look at Value Before we get into the numbers, if you are wondering whether BioMarin Pharmaceutical’s current share price fairly reflects its long term potential, it helps to first step back and see what the market has been doing with the stock lately. BioMarin’s share price closed at US$58.51 most recently, with returns of 4.3% decline over the past week, 3.0% decline over the past month, a 1.6% decline year to date, and a 15.7%...
NasdaqGS:CNXC
NasdaqGS:CNXCProfessional Services

Reassessing Concentrix (CNXC) Valuation After Sectorwide Sell Off On Geopolitical Uncertainty

Investor sentiment toward Concentrix (CNXC) came under pressure as escalating geopolitical tensions triggered a broad risk off move, pulling down business process outsourcing and consulting stocks alongside the wider sector. See our latest analysis for Concentrix. At a recent share price of US$31.67, Concentrix has seen a 7 day share price return of about a 10% decline and a year to date share price return of roughly a 23% decline. The 1 year total shareholder return of around a 28% decline...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Why Adobe (ADBE) Is Down 12.1% After CEO Transition Plans And AI-Focused Strategy Update – And What's Next

Adobe reported first-quarter 2026 results with revenue of US$6.40 billion and net income of US$1.89 billion, while also issuing second-quarter guidance and confirming a leadership transition as long‑time CEO Shantanu Narayen plans to step down once a successor is appointed. Beyond the headline earnings beat, the combination of Narayen’s planned departure, an extensive share repurchase program, and growing AI‑related partnerships such as the expanded Major League Baseball deal is reshaping...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Why Capital Clean Energy Carriers (CCEC) Is Down 6.1% After Naming Martin Houston Chairman And Posting US$392.71 Million In 2025 Sales – And What's Next

Capital Clean Energy Carriers Corp. recently reported fourth-quarter 2025 sales of US$98.35 million and full-year sales of US$392.71 million, alongside appointing veteran energy executive Martin Houston as Chairman and moving Keith Forman to Vice-Chairman. The combination of higher annual sales and earnings per share from continuing operations with Houston’s extensive global energy leadership experience could meaningfully influence how investors assess the company’s long-term...
NasdaqGS:EWTX
NasdaqGS:EWTXPharmaceuticals

Edgewise Therapeutics (EWTX) Is Up 6.4% After New Long-Term Becker Data On Sevasemten Trial

Edgewise Therapeutics recently presented long-term data from its MESA open-label extension study of sevasemten in Becker muscular dystrophy at the 2026 MDA Clinical and Scientific Conference, showing multi-year stabilization of patient function and a favorable safety profile in a disease with no approved therapies. An unusually high 99% of eligible participants from earlier sevasemten trials chose to continue into the MESA extension, underscoring sustained engagement with the investigational...
NYSE:DINO
NYSE:DINOOil and Gas

Assessing HF Sinclair (DINO) Valuation After Acting CFO Appointment

Executive change at HF Sinclair HF Sinclair (DINO) has appointed Mr. Vivek Garg as acting Chief Financial Officer, a move that puts fresh attention on leadership stability and financial oversight for investors tracking the stock. See our latest analysis for HF Sinclair. HF Sinclair’s 1-day share price return of a 2.72% decline and 1-month share price return of a 5.16% decline sit against a stronger 90-day gain of 12.84% and 1-year total shareholder return of 79.84%. This contrast highlights...
ENXTPA:MAU
ENXTPA:MAUOil and Gas

Assessing Maurel & Prom’s Valuation As Higher 2025 Profit And 2026 Production Plans Lift Confidence

Etablissements Maurel & Prom (ENXTPA:MAU) has drawn fresh attention after reporting higher net income for 2025 despite lower sales, pairing that outcome with a proposed dividend increase and detailed production guidance for 2026. See our latest analysis for Etablissements Maurel & Prom. The earnings announcement and renewed focus on M&A have arrived alongside very strong share price momentum, with a 30 day share price return of 45.06% and a 90 day share price return of 112.49%, while the 1...
NasdaqCM:MBIN
NasdaqCM:MBINDiversified Financial

A Look At Merchants Bancorp (MBIN) Valuation After Its Latest Earnings Beat

Merchants Bancorp (MBIN) is back in focus after its latest earnings report showed revenues, EPS, and net interest income all ahead of analyst estimates, highlighting its low-risk, government-backed lending model. See our latest analysis for Merchants Bancorp. The latest earnings beat comes after a mixed price pattern, with a 10.52% 1 month share price decline, a 14.99% 3 month share price return, and a 25.56% year to date share price return, alongside a 63.14% 3 year total shareholder return...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Assessing Golar LNG (GLNG) Valuation After Strait Of Hormuz Disruption To Global LNG Flows

Market shock around LNG flows puts Golar LNG in focus A conflict driven closure of shipping routes in the Strait of Hormuz has disrupted roughly 19% of global LNG exports, injecting fresh volatility into gas markets and pulling Golar LNG (GLNG) into sharper investor focus. See our latest analysis for Golar LNG. The LNG route disruption comes after a choppy few weeks for Golar LNG, with a 1-day share price return of a 4.13% decline and a 7-day share price return of an 8.79% decline. However, a...
XTRA:DHER
XTRA:DHERHospitality

Assessing Delivery Hero (XTRA:DHER) Valuation As Activist Investor Pressures Restructuring And Asset Sales

Delivery Hero (XTRA:DHER) is back in focus after major shareholder Aspex Management pushed for asset sales and a slimmer business structure, citing weak profitability, leadership concerns, and a sizeable European Commission fine. See our latest analysis for Delivery Hero. The recent activist push comes after a tough stretch for investors, with a 30 day share price return of 22.69% decline and a 1 year total shareholder return of 29.11% decline signaling that momentum has been fading rather...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

Can Pega’s New AI “Vibe Coding” Tools Redefine Its Workflow Automation Edge for Investors (PEGA)?

Pegasystems recently expanded its Pega Blueprint offering with an end-to-end “vibe coding” experience, enabling conversational AI-driven app design at enterprise scale while maintaining governance, security, and maintainability. A fresh endorsement from Forrester as a Leader in customer service solutions, alongside these AI-powered workflow tools, highlights Pega’s push to make complex enterprise automation more accessible to both business and technical users. We’ll now examine how Pega’s...
NYSE:CCK
NYSE:CCKPackaging

What Crown Holdings (CCK)'s Operationally Driven 2025 Earnings Strength Means For Shareholders

In recent days, Crown Holdings reported strong fiscal 2025 results, with revenue and earnings growth supported by European shipments and favorable currency effects, while Jefferies reaffirmed its positive view citing the company’s advanced Bowling Green manufacturing plant. Beyond headline growth, the emphasis on high-tech, efficient production at Bowling Green underlines how manufacturing quality and innovation are becoming central to Crown’s competitive position. Now we’ll explore how this...
NYSE:NOW
NYSE:NOWSoftware

Is ServiceNow's (NOW) AI 'Control Tower' Strategy Deepening Its Cross‑Industry Moat?

In recent days, ServiceNow has expanded its AI footprint with new public sector offerings like EmployeeWorks and Autonomous Workforce, while partners including Cohesity, Aiva Health, Autonomize AI, NTT DOCOMO and StarHub announced integrations that embed ServiceNow’s AI platform into data security, healthcare, telecom roaming and payer operations workflows. Together with fresh recognition in a Forrester public sector cloud report and new ESOP-related shelf registrations, these moves...
NYSE:NOG
NYSE:NOGOil and Gas

How Northern Oil and Gas’ US$200 Million Equity Raise (NOG) Has Changed Its Investment Story

In March 2026, Northern Oil and Gas, Inc. completed a follow-on equity offering of approximately US$200.00 million, issuing 7,207,208 common shares at US$27.75 each and granting underwriters a 30-day option to purchase up to an additional 1,081,081 shares. This sizable capital raise, which increases the company’s share count, highlights management’s willingness to tap equity markets to support its growth and acquisition agenda. We’ll now examine how this sizeable equity issuance, and the...
NYSE:VLTO
NYSE:VLTOCommercial Services

Is Veralto (VLTO) Offering an Opportunity After Recent Share Price Declines?

If you are wondering whether Veralto, at around US$90.20, is offering fair value right now or if the market is mispricing it, this article walks you through what the numbers actually say. The stock has recently been under pressure, with a 7 day return of a 4.4% decline, a 30 day return of a 5.1% decline and a year to date return of an 8.4% decline, adding to a 1 year return of a 7.5% decline. Recent coverage around Veralto has focused on how the newly listed business fits into the broader...
ENXTPA:FR
ENXTPA:FRAuto Components

Is Valeo (ENXTPA:FR) Now Attractively Priced After Recent Share Price Rebound?

If you are wondering whether Valeo at €10.37 is a bargain or a value trap, you are in the right place for a clear look at what the current price might actually represent. The share price has moved by 3.5% over the last week, 21.1% over the last month, and 14.9% year to date, while the 1 year return sits at 11.3%, the 3 year at 34.0% and the 5 year at 61.4% declines, which can change how investors view both its potential and its risks. Recent headlines around Valeo have focused on its...
ASX:NCK
ASX:NCKSpecialty Retail

Assessing Nick Scali (ASX:NCK) Valuation After The Appointment Of New CFO And Company Secretary

Interest in Nick Scali (ASX:NCK) has picked up after the company appointed Keith Toms as both Chief Financial Officer and Company Secretary, putting fresh focus on its leadership and financial stewardship. See our latest analysis for Nick Scali. The appointment of Keith Toms comes at a time when the A$15.95 share price has faced a 30 day share price return decline of 32.95% and a 90 day share price return decline of 26.19%. This is despite the 5 year total shareholder return of 116.93%, which...
NYSE:TEX
NYSE:TEXMachinery

Is Terex (TEX) Offering Value After Recent Pullback And Strong Multi Year Gains

If you are wondering whether Terex shares are still offering value at current levels, you are not alone. This article will walk through what the market price might be implying about the business. The stock last closed at US$59.41, with returns of 8.0% year to date and 49.4% over the past year. However, a 4.3% decline over the last week and a 14.0% decline over the last month shows sentiment has recently cooled. These short term moves sit against a longer backdrop where Terex has also...
ASX:ZIP
ASX:ZIPConsumer Finance

Does Zip Co (ASX:ZIP)’s Shifting Shareholder Mix Quietly Recast Its Long‑Term Investment Story?

In March 2026, Zip Co Limited issued 1,508,159 new fully paid ordinary shares from converted unquoted securities, while Australian Retirement Trust exited as a substantial shareholder and CEO Cynthia Scott converted vested performance rights into ordinary shares. Together, these past transactions slightly expanded Zip’s equity base, reshaped its institutional investor mix, and reaffirmed management’s economic alignment with other shareholders. We’ll now examine how the Australian Retirement...